Bridger Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bridger Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-847,094	Closed	-$7.03M	–	51
2015 Q2	$7.03M	Buy	+847,094	New	+$4.11M	0.22%	40
2013 Q3	–	Sell	-1,079,251	Closed	-$4.6M	–	46
2013 Q2	$4.6M	Buy	+1,079,251	New	+$5.42M	0.34%	37

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Bridger Management's SGYP Position: Q3 2015 in Review

Bridger Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2015, closing a stake of 847,094 shares — an estimated $7.03M sold.

Bridger Management first reported a position in SGYP in Q2 2013 and held it in 2 quarters. The position peaked at $7.03M in Q2 2015. 129 funds tracked by Wall St. Rank hold SGYP as of Q3 2015.

Bridger Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2015 after selling out during the quarter.
Bridger Management sold 847,094 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2015, an estimated $7.03M.
Bridger Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 2 quarters.
Bridger Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $7.03M in Q2 2015.
129 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2015.

Based on Bridger Management's 13F filing for Q3 2015, filed 16 Nov 2015.